This page includes the latest FDA filings for Eyepoint Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | EYPT | DUNS 008225658 |
Device Company | Device | Date |
|---|---|---|
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2025-01-25 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2023-12-23 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2023-10-17 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2022-12-23 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2021-12-21 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2021-12-15 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2020-09-11 |
| EyePoint Pharmaceuticals, Inc | Prescription Medication | 2019-02-15 |
| EyePoint Pharmaceuticals, Inc | YUTIQ | 2018-10-12 |
| NCAGE Code | 89D47 | EYEPOINT PHARMACEUTICALS, INC. |
| CAGE Code | 89D47 | EYEPOINT PHARMACEUTICALS, INC. |
| SEC | 0001314102 | EyePoint Pharmaceuticals, Inc. of DELAWARE |